Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment.

MLA

Juniastuti, et al. “Interleukin-28B Polymorphisms and Response of Chronic Hepatitis C Patients from Indonesia to Pegylated Interferon/Ribavirin Treatment.” Journal of Clinical Microbiology, vol. 52, no. 6, June 2014, pp. 2193–95. EBSCOhost, https://doi.org/10.1128/JCM.00768-14.

APA

Juniastuti, Wibowo, B. P., Wibawa, I. D. N., Utsumi, T., Mustika, S., Amin, M., Wahyuni, R. M., Kurniawan, H., Hendrayana, A., Setiawan, P. B., Yamani, L. N., Soetjipto, Yano, Y., Hotta, H., Hayashi, Y., & Lusida, M. I. (2014). Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment. Journal of Clinical Microbiology, 52(6), 2193–2195. https://doi.org/10.1128/JCM.00768-14

Chicago

Juniastuti, Bogi P Wibowo, I D N Wibawa, Takako Utsumi, Syifa Mustika, Mochamad Amin, Rury M Wahyuni, et al. 2014. “Interleukin-28B Polymorphisms and Response of Chronic Hepatitis C Patients from Indonesia to Pegylated Interferon/Ribavirin Treatment.” Journal of Clinical Microbiology 52 (6): 2193–95. doi:10.1128/JCM.00768-14.